Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 12, 2016

Total Value ($000): $277,542 (100.0% shares, 0.0% debt)

Holdings (20)

UTHR UNITED THERAPEUTICS CORP 10.5%
Value ($000) $29,154 Shares 275,248 Est. Cost $136.10 Unrealized -18.0%
OM2 ORTHOFIX INTERNATIONAL NV 9.9%
Value ($000) $27,409 Shares 646,446 Est. Cost $32.01 Unrealized
IMPAX LABORATORIES INC 7.6%
Value ($000) $21,062 Shares 730,817 Est. Cost $33.19 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 7.2%
Value ($000) $19,998 Shares 906,930 Est. Cost $37.63 Unrealized -30.4%
TEVA TEVA PHARMACEUTICAL-SP ADR 7.2%
Value ($000) $19,918 Shares 396,545 Est. Cost $58.35 Unrealized
AMGEN INC 6.9%
Value ($000) $19,141 Shares 125,802 Est. Cost $152.19 Unrealized
HALYARD HEALTH INC 6.7%
Value ($000) $18,706 Shares 575,206 Est. Cost $40.74 Unrealized
SUCAMPO PHARMACEUTICALS-CL A 6.4%
Value ($000) $17,896 Shares 1,631,398 Est. Cost $12.18 Unrealized
INDIVIOR PLC 5.7%
Value ($000) $15,800 Shares 4,727,970 Est. Cost $3.34 Unrealized
CNMD CONMED CORP 5.7%
Value ($000) $15,710 Shares 329,142 Est. Cost $37.99 Unrealized +0.6%
MRK MERCK & CO. INC. 5.3%
Value ($000) $14,837 Shares 257,538 Est. Cost $39.26 Unrealized +0.6%
RTI SURGICAL INC 4.7%
Value ($000) $13,096 Shares 3,648,001 Est. Cost $4.60 Unrealized
SHIRE PLC-ADR 4.2%
Value ($000) $11,628 Shares 63,166 Est. Cost $184.09 Unrealized
INVACARE CORP 3.9%
Value ($000) $10,934 Shares 901,440 Est. Cost $14.51 Unrealized
ALLERGAN PLC 2.2%
Value ($000) $6,104 Shares 26,416 Est. Cost $303.07 Unrealized
DEPOMED INC 1.5%
Value ($000) $4,275 Shares 217,904 Est. Cost $16.75 Unrealized
AVIRAGEN THERAPEUTICS INC 1.4%
Value ($000) $3,791 Shares 2,708,438 Est. Cost $1.40 Unrealized
DERMA SCIENCES INC 1.3%
Value ($000) $3,588 Shares 910,703 Est. Cost $4.57 Unrealized
DIGIRAD CORP 0.9%
Value ($000) $2,478 Shares 481,218 Est. Cost $4.41 Unrealized
JUNIPER PHARMACEUTICALS INC 0.7%
Value ($000) $2,017 Shares 287,755 Est. Cost $9.19 Unrealized